Urolithins in clinical translation: from gut microbial metabolites to precision interventions

鞣花酸 计算生物学 生物 生物信息学 临床试验 疾病 肠道菌群 一致性 转化研究 心理干预 人体研究 临床研究设计 代谢组学 人体微生物群 代谢物 人类疾病 医学 药理学 微生物群 细胞代谢 生物技术 背景(考古学) 生物信息学 基因组 蛋白质组学 药物发现
作者
Lingmin Hu,Yingchun Ling,Weifeng Jin
出处
期刊:Frontiers in Nutrition [Frontiers Media]
卷期号:13: 1854240-1854240 被引量:2
标识
DOI:10.3389/fnut.2026.1854240
摘要

Urolithins are gut microbiota-derived metabolites generated from ellagitannins and ellagic acid, and have emerged as promising mediators at the diet–microbiota–host interface. Interest in this metabolite family has increased substantially owing to growing evidence that urolithins, particularly urolithin A, influence mitochondrial quality control, autophagy, inflammatory signaling, and metabolic homeostasis across multiple tissues. These mechanistic properties have positioned urolithins as candidate interventions for aging-related functional decline, cardiometabolic disorders, neuroinflammatory conditions, and other chronic diseases characterized by impaired cellular resilience. However, their path to clinical application remains incompletely defined. In this Review, we synthesize current knowledge on the origin, microbial biotransformation, metabotypes, pharmacokinetics, and exposure biology of urolithins, with particular attention to the determinants of interindividual variability and the unresolved question of which molecular species are truly active in vivo . We then examine the core mechanisms of urolithin action and evaluate evidence across major disease contexts, integrating pre-clinical findings with available human data. Particular emphasis is placed on the current clinical literature on urolithin A, including safety, tolerability, dosing, target-engagement biomarkers, and functional endpoints. We further analyze the major factors underlying the translational gap between experimental promise and clinical outcomes, including differences in microbial production capacity, free vs. conjugated molecular forms, exposure–response uncertainty, responder heterogeneity, and limitations in trial design. Finally, we discuss how metabotype-guided stratification, microbiome-targeted strategies, improved formulations, and standardized biomarkers may support the development of urolithins within precision nutrition and translational medicine. Collectively, urolithins represent a compelling yet still evolving class of diet-derived microbial metabolites whose clinical utility will depend on resolving key mechanistic, pharmacological, and methodological uncertainties.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bkagyin的应助被Samuel采纳,获得10
1秒前
1035646426发布了新的文献求助10
2秒前
小蘑菇的应助被冷傲的迎荷采纳,获得20
2秒前
乐观铅笔完成签到,获得积分10
2秒前
taoliu完成签到,获得积分10
4秒前
酸梅汤完成签到 ,获得积分10
4秒前
5秒前
6秒前
6秒前
充电宝的应助被顺利的蘑菇采纳,获得10
6秒前
Ziqi发布了新的文献求助100
6秒前
6秒前
CodeCraft的应助被陆羽采纳,获得10
9秒前
lxz完成签到,获得积分20
9秒前
安风完成签到 ,获得积分10
9秒前
Marpple完成签到,获得积分10
10秒前
anna1992发布了新的文献求助10
11秒前
新新点灯完成签到,获得积分10
11秒前
大胆冰棍发布了新的文献求助10
11秒前
郭潇阳发布了新的文献求助20
12秒前
molihuakai的应助被West采纳,获得10
12秒前
不来也不去完成签到,获得积分10
12秒前
呵呵发布了新的文献求助10
13秒前
hhhhh完成签到 ,获得积分10
14秒前
14秒前
高兴的海豚完成签到,获得积分10
14秒前
敏家发布了新的文献求助10
15秒前
大模型的应助被老实的硬币采纳,获得10
15秒前
kklove发布了新的文献求助10
15秒前
16秒前
Jasper的应助被科研通管家采纳,获得10
16秒前
酷波er的应助被科研通管家采纳,获得10
16秒前
贪玩的新筠完成签到,获得积分10
16秒前
情怀的应助被科研通管家采纳,获得10
16秒前
aa的应助被科研通管家采纳,获得10
17秒前
Owen的应助被科研通管家采纳,获得10
17秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
17秒前
17秒前
17秒前
我是谁的应助被科研通管家采纳,获得20
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163614
求助须知:如何正确求助?哪些是违规求助? 9557702
关于积分的说明 21741573
捐赠科研通 7754282
什么是DOI,文献DOI怎么找? 3428275
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472923